Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians

BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Amerta, Gupta, Ritesh, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of Diabetes India. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129346/
https://www.ncbi.nlm.nih.gov/pubmed/32283497
http://dx.doi.org/10.1016/j.dsx.2020.04.001
_version_ 1783516765006856192
author Ghosh, Amerta
Gupta, Ritesh
Misra, Anoop
author_facet Ghosh, Amerta
Gupta, Ritesh
Misra, Anoop
author_sort Ghosh, Amerta
collection PubMed
description BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19 up to 31(st) March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. RESULTS: We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. CONCLUSIONS: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.
format Online
Article
Text
id pubmed-7129346
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd on behalf of Diabetes India.
record_format MEDLINE/PubMed
spelling pubmed-71293462020-04-08 Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians Ghosh, Amerta Gupta, Ritesh Misra, Anoop Diabetes Metab Syndr Article BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19 up to 31(st) March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. RESULTS: We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. CONCLUSIONS: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required. Published by Elsevier Ltd on behalf of Diabetes India. 2020 2020-04-04 /pmc/articles/PMC7129346/ /pubmed/32283497 http://dx.doi.org/10.1016/j.dsx.2020.04.001 Text en © 2020 Published by Elsevier Ltd on behalf of Diabetes India. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ghosh, Amerta
Gupta, Ritesh
Misra, Anoop
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title_full Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title_fullStr Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title_full_unstemmed Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title_short Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
title_sort telemedicine for diabetes care in india during covid19 pandemic and national lockdown period: guidelines for physicians
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129346/
https://www.ncbi.nlm.nih.gov/pubmed/32283497
http://dx.doi.org/10.1016/j.dsx.2020.04.001
work_keys_str_mv AT ghoshamerta telemedicinefordiabetescareinindiaduringcovid19pandemicandnationallockdownperiodguidelinesforphysicians
AT guptaritesh telemedicinefordiabetescareinindiaduringcovid19pandemicandnationallockdownperiodguidelinesforphysicians
AT misraanoop telemedicinefordiabetescareinindiaduringcovid19pandemicandnationallockdownperiodguidelinesforphysicians

Ejemplares similares